Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain

Patent portfolio with over 100 patents, issued and pending, protects technology targeting a $100 billion market opportunity Company developing potential breakthrough two-fold technology that can potentially detect

GlobeNewswireApr 16 21:00

Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology

Yahoo FinanceApr 16 00:03

Autonomix Announces Positive Preclinical Study for Its Catheter-based Sensing Technology

Seeking AlphaApr 9 20:54

Autonomix Announces Positive Findings From Preclinical Study Demonstrating Potential to Improve Renal Denervation

Globe NewswireApr 9 20:30

Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker

Live webcast with members of the Autonomix management team, on Thursday, April 11th at 12:00 PM ET THE WOODLANDS, TX, April 08, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the

GlobeNewswireApr 8 20:30

Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference

Live webcast presentation on Thursday, April 4th at 3:55 PM ET THE WOODLANDS, TX, March 27, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ:AMIX) ("Autonomix" or the "Company"), a medical device company

GlobeNewswireMar 27 21:00